Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the three months ended March 31, 2024, and other recent developments.

Fiscal Q3 Revenue up 15% to $23.3 Million Driven In-Part byAccelerated Growth of iPower SuperSuite Business Gross Margin Expansion and Improved Operating LeverageEnables Return to Profitability Strong Fiscal Q3 Performance Lays Foundation for Further Growth and Profitability DUARTE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home, pet and garden products, as well as a provider of value-added ecommerce services, today announced its financial results for the fiscal third quarter ended March ...

AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions, today announced its results for the first quarter ended March 31, 2024.

Total Revenue Increased 61% Year-over-Year; Mobile Revenue Grew nearly 200% Year-over-Year, Reaching a Record 61% of Total Revenue PORTLAND, Ore., May 14, 2024 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today announced financial results for the first quarter ended March 31, 2024.